Table 2 Variables description along study visits (n = 162), Goiânia—GO
Visit 1 | Visit 2 | Visit 3 | p valuea | |
|---|---|---|---|---|
Systolic BP (mmHg) | 140.2 (± 19.9) | 136.2 (± 20.2) | 133.5 (± 18.6) | 0.002 |
Diastolic BP (mmHg) | 87.7 (± 12.9) | 83.7 (± 12.0) | 79.6 (± 11.1) | < 0.001 |
Total cholesterol (mg/dL) | 206.8 (± 52.0) | 187.3 (± 47.1) | 175.8 (± 43.2) | < 0.001 |
LDL-cholesterol (mg/dL) | 120.8 (± 43.4) | 107.6 (± 37.1) | 100.3 (± 35.8) | < 0.001 |
HDL-cholesterol (mg/dL) | 42.2 (± 9.9) | 42.1 (± 10.3) | 43.2 (± 9.9) | 0.207 |
Triglycerides (mg/dL) | 220.0 (± 160.7) | 200.7 (± 173.7) | 176.4 (± 125.7) | < 0.001 |
Fasting glucose (mg/dL) | 149.6 (± 65.8) | 137.0 (± 49.7) | 147.8 (± 53.6) | 0.515 |
HbA1C (%) | 7.9 (± 1.6) | 7.7 (± 1.7) | 7.3 (± 1.5) | < 0.001 |
GFR (mL/min) | 78.3 (± 21.5) | 72.8 (± 21.1) | 66.3 (± 21.0) | < 0.001 |
Smoke | 8 (4.9%) | 5 (3.1%) | 5 (3.1%) | 0.378 |
Alcohol consumption | 14 (8.6%) | 7 (4.3%) | 5 (3.1%) | 0.026 |
Sedentary lifestyle | 20 (12.4%) | 34 (21.0%) | 26 (16.1%) | 0.369 |
Predicted Framingham 10-year cardiovascular risk | ||||
Low | 19 (11.7%) | 16 (9.9%) | 15 (9.3%) | 0.465 |
Intermediate | 44 (27.2%) | 53 (32.7%) | 55 (33.9%) | 0.188 |
High | 42 (25.9%) | 40 (24.7%) | 40 (24.7%) | 0.798 |
Very high | 57 (35.2%) | 53 (32.7%) | 52 (32.1%) | 0.556 |